Add time:07/19/2019         Source:sciencedirect.com

ObjectiveThere is considerable uncertainty regarding the optimal use of Rifampicin (cas 13292-46-1) for the treatment of tuberculous (TB) meningitis. A pharmacokinetic modeling and simulation study of rifampicin concentrations in cerebrospinal fluid (CSF) during TB meningitis treatment was performed in this study.

We also recommend Trading Suppliers and Manufacturers of Rifampicin (cas 13292-46-1). Pls Click Website Link as below: cas 13292-46-1 suppliers